Solo CCRP Control Kit 1x0.5Ml

Target species Dogs Indications for use Treatment of flea infestations (Ctenocephalides felis); the product has persistent insecticidal efficacy for up to 4 weeks against Ctenocephalides felis. The product has persistent acaricidal efficacy for up to 5 weeks against Ixodes ricinus and up to 3 weeks against Rhipicephalus sanguineus. If ticks of these species are present when the product is applied, all the ticks may not be killed within the first 48 hours but they may be killed within a week. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl Tick Plus treated pets. Contra-indications DO NOT USE IN CATS Do not use in case of known hypersensitivity to the active substances or to any of the excipients. Special warnings for each target species None Special precautions for use Special precautions for use in animals The safety of Activyl Tick Plus has not been established in dogs younger than 8 weeks of age. The safety of Activyl Tick Plus has not been established in dogs weighing less than 1.2 kg. Care should be taken to avoid contact of the veterinary medicinal product with the eyes of the dog. Avoid contact with treated areas (application sites) until dry. The veterinary medicinal product remains effective when treated animals are exposed to sunlight or immersed in water (e.g. swimming, bathing). However, dogs should not be allowed to swim or be shampooed within 48 hours after treatment. In case of frequent shampooing, the duration of activity may be reduced. Ticks already attached on the dog may not be killed within two days after treatment and may remain attached and visible. Therefore the removal of ticks already on the dog at the time of treatment is recommended, in order to prevent them from attaching and having a blood meal. The veterinary medicinal product can induce convulsions in cats that could be fatal, due to the unique physiology of this species which is unable to metabolise certain compounds, including permethrin. In case of accidental exposure, if undesirable effects occur, wash the cat with shampoo or soap, and seek veterinary advice rapidly. To prevent cats from being accidentally exposed to the product, keep treated dogs away from cats until the application site is dry. It is important to ensure that cats do not groom the site of application on a dog, which has been treated with this product. In case of exposure of this type seek veterinary advice immediately. Special precautions to be taken by the person administering the veterinary medicinal product to animals Do not eat, drink or smoke while handling the veterinary medicinal product. The sachet is child-resistant. Keep the product in the sachet until use, in order to prevent children from getting direct access to the product. Keep the used pipette out of sight and reach of children. Used pipettes should be disposed of immediately. Wash hands immediately after use. This product contains indoxacarb and permethrin. People with known hypersensitivity to indoxacarb and/or permethrin should avoid contact with this product. As the veterinary medicinal product may cause moderate eye irritation, avoid contact with eyes. If this occurs, rinse slowly and gently with water. This product is highly flammable. Keep away from heat, sparks, open flame or other sources of ignition. Adverse reactions Transitory scratching, erythema or hair loss at the application site may occur. These effects will usually resolve without treatment. In very rare cases, gastrointestinal signs (e.g. emesis, diarrhoea or anorexia), reversible neurological signs (e.g. tremor or ataxia) or lethargy have been observed. These signs are usually transient and generally resolve within 24-48 hours. The application of the veterinary medicinal product may produce a local, temporary oily appearance or hair clumping at the application site. A dry white residue may be also observed. This is normal and will generally resolve within a couple of days after administration. These changes do not affect the safety or efficacy of the veterinary medicinal product. The frequency of adverse reactions is defined using the following convention: − very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment) − common (more than 1 but less than 10 animals in 100 animals) − uncommon (more than 1 but less than 10 animals in 1,000 animals) − rare (more than 1 but less than 10 animals in 10,000 animals) − very rare (less than 1 animal in 10,000 animals, including isolated reports). Use during pregnancy, lactation or lay Laboratory animal studies (rats, mice and rabbits) with indoxacarb and permethrin have not produced any evidence of a teratogenic, foetotoxic or materno toxic effects. However, a reproductive toxicity study conducted in the dog at three times the recommended therapeutic dose did reveal a significant reduction in the live pup ratio; the clinical significance of this latter finding is unknown as no studies were carried out in dogs using the recommended therapeutic dose. Pregnancy: Use only accordingly to the benefit-risk assessment by the responsible veterinarian. Lactation: Use only accordingly to the benefit-risk assessment by the responsible veterinarian. Fertility: Use only accordingly to the benefit-risk assessment by the responsible veterinarian. Interactions None known
Vat Rate: 20%